IJMS | Free Full-Text | PD-1 Independent Role of PD-L1 in Triple-Negative Breast Cancer Progression
Recombinant Anti-PD-L1 antibody [EPR20529] KO Tested (ab213480) | Abcam
PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer | Cell Death & Disease